Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02314104 · ClinicalTrials.gov registry record · NA

Efficacy of Transversus Abdominis Plane Block Versus Local Injection of Pain Medication

A NA study of Pain, Postoperative, sponsored by Liberman, Eric, D.O..

Completed
Registry status
NA
Development phase
220
Enrollment target
1
Study location

NCT02314104 is a NA study of Pain, Postoperative that has completed, run by Liberman, Eric, D.O.. The registered enrollment target is 220 participants, below the 271-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02314104, a NA study of Pain, Postoperative, has completed, sponsored by Liberman, Eric, D.O..

COMPLETED
Registry status
NA
Development phase
220 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if there is a better method of administering pain medication prior to minimally invasive gynecological surgery so that postoperative pain and/or narcotic usage may be minimized. Currently, no standard of care exists regarding the use of local pain medications in minimally invasive gynecological surgery and practices vary widely among physicians, even within the same institution. The two methods of preemptive pain medication that this study will be looking at is the transversus abdominis plane (TAP) block and the local injection of pain medication at the areas of the skin incisions. TAP block is a procedure performed by a specially trained pain management anesthesiologist in which there is an injection of a local pain medication into the abdominal wall, specifically in a space where the nerves that are responsible for postoperative pain reside. This procedure blocks the ability of the nerves to sense pain and has been found to be successful in decreasing postoperative pain in a number of procedures. The local injection of pain medications at the incision sites has also been found to be beneficial in decreasing postoperative pain. However, it is not known whether one method is superior to the other in decreasing postoperative pain or if the combination of both is best. Patients that chose to participate are randomly (by chance) assigned to one of three groups: 1) TAP block with pain medication and local injection of normal saline (water) at the incision sites 2) TAP block with normal saline and local injection of pain medication at the incision sites or 3) TAP block with pain medication and local injection of pain medication at the port sites. These procedures are performed while the patient is asleep. Patients will be asked to record their level of pain on a standardized pain scale at one hour, six hours, and twenty-four hours after the surgery. All patients are provided with standard postoperative pain medications as neede

Conditions Studied

Interventions

  • DRUG ropivacaine

Study Locations (1)

New Jersey

  • Saint Barnabas Medical Center - Livingston

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2011-05
Est. Completion 2013-10
Phase NA

Sponsor

Liberman, Eric, D.O.

1 total trials

What the Registry Record Tells You About NCT02314104

The ClinicalTrials.gov registry entry for NCT02314104 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 271-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (19% lower). The listed sponsor is Liberman, Eric, D.O., which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which ropivacaine is the first listed.

NCT02314104 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT02314104 about?

NCT02314104 is a clinical study titled "Efficacy of Transversus Abdominis Plane Block Versus Local Injection of Pain Medication". The purpose of this study is to determine if there is a better method of administering pain medication prior to minimally invasive gynecological surgery so that postoperative pain and/or narcotic usage may be minimized. Currently, no standard of care exists regarding the use of local pain medication...

What is the current status of trial NCT02314104?

This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2011-05. Estimated completion is 2013-10.

What conditions does trial NCT02314104 study?

This clinical trial studies the following conditions: Pain, Postoperative.

What interventions are being tested in trial NCT02314104?

The interventions under investigation include: ropivacaine (DRUG).

Who is sponsoring clinical trial NCT02314104?

This trial is sponsored by Liberman, Eric, D.O., which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02314104 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.